Article Details

GSK and Alector to develop antibodies for neurodegenerative diseases

Retrieved on: 2021-07-05 11:26:15

Tags for this article:

Click the tags to see associated articles and topics

GSK and Alector to develop antibodies for neurodegenerative diseases. View article details on hiswai:

Excerpt

GlaxoSmithKline (GSK) and Alector have entered a strategic global alliance to develop and market two monoclonal antibodies, AL001 and AL101, for ...

Article found on: www.pharmaceutical-technology.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo